Many DNA tumor virus oncogenes are capable of activating and highjacking the host cell's DNA replication machinery for its own reproduction purposes through targeting and inactivation of the retinoblastoma pocket protein family. Pocket proteins function to regulate cell cycle progression and DNA synthesis through inhibitory interactions with the E2F transcription factors. The interaction of viral oncogenes with the pocket proteins is crucial for their transforming activity. We recently demonstrated that the DNA methyltransferase 1 (DNMT1) gene is an E2F target gene that is transcriptionally activated in cells lacking the retinoblastoma gene (Rb À/À ). Overexpression of DNMT1 is implicated in tumor suppressor gene hypermethylation which is associated with tumorigenesis. Given that viral oncogenes potently stimulate E2F activity, we hypothesized that viral infection might activate DNMT1 and thereby promote transformation. Herein, we demonstrate that DNMT1 is strongly activated by the human polyomavirus BKV large T antigen (TAg) and adenovirus E1a. Viral oncogene mutants incapable of binding the pocket proteins are ineffective at activating DNMT1 compared to their wildtype counterparts. Additionally, mutation of the E2F sites within the DNMT1 promoters dramatically abrogates transcriptional activation. These data suggest that viral induction of DNMT1 through modulation of the pRB/ E2F pathway may be involved in viral transformation.
Introduction
DNA tumor virus infection has been implicated in the etiology of many cancers including malignant mesotheliomas, non-Hodgkin's lymphoma and tumors of the bone, brain and urinary tract (Khalili et al., 2003; Tognon et al., 2003; Vilchez and Butel, 2004) . The most commonly explored role for viruses in cancer involves the expression of viral oncogenes, such as polyomavirus large T antigens (TAg), adenovirus E1a and E1b, and papillomavirus E6 and E7 (O'Shea, 2005) . These proteins share the ability to interact with and inactivate the pocket protein family (pRb, p107, p130) and/or the p53 tumor suppressor (DeCaprio et al., 1988; Nakshatri et al., 1988; Bollag et al., 1989; Harris et al., 1996) . Inhibition of the pocket proteins by viral oncogenes activates the cellular DNA replication machinery needed to replicate the viral genome for packaging into progeny virions (Pipas, 1992; Campbell et al., 1997) . As a side effect of activating the cellular DNA replication machinery and other genes involved in S phase progression, viruses promote increased cellular proliferation, delayed differentiation, and often malignant transformation (Syrjanen and Syrjanen, 1999) .
Cellular DNA replication and S phase progression are in large-part controlled by the E2F family of transcription factors (Johnson et al., 1993) . E2F activity, in turn, is negatively regulated by the pocket protein family members, which bind to the E2Fs in various combinations and recruit histone deacetylases to E2F target gene promoters (Chellappan et al., 1991; Brehm et al., 1998) . Therefore, through interactions with the pocket proteins, viral oncogenes such as TAg, E1a and E7 are capable of stimulating E2F transactivation activity and promoting DNA replication. While aberrantly increased DNA replication and proliferation are hallmarks of transformation and cancer, replicating cells are not necessarily malignant suggesting that secondary genetic or epigenetic events are also involved in virus-associated transformation.
Indeed, SV40 TAg may promote secondary genetic alterations through its inhibition of p53 and other DNA repair proteins which coordinate a DNA damage response following chromosome breakage, homologous recombination, or radiation-or chemical-induced DNA damage (Ray et al., 1990; Trabanelli et al., 1998) . Also, E6 and E7 proteins from the high-risk human papillomaviruses uncouple centrosome duplication from cell division leading to aberrant mitotic spindle pole formation and genomic instability (Duensing et al., 2000) . However, while genetic perturbations have been shown to play key roles in viral transformation, epigenetic modifications such as DNA methylation may also play important roles during viral infection and transformation. For example, neonatal hamster kidney cells transformed with adenovirus type 12 exhibit a 40% increase in genomic cytosine methylation (Gunthert et al., 1976) . While it is thought that this increased DNA methylation may be part of a host defense mechanism attempting to silence expression of foreign DNA (Sutter and Doerfler, 1980) , it is also clear that viral infection affects de novo methylation and transcription of cellular genes as well (Heller et al., 1995; Remus et al., 1999; Hohlweg et al., 2003) .
DNA methylation is an epigenetic modification that occurs on cytosines located 5 0 to guanosines. DNA methylation patterns are created and maintained by three known active DNA methyltransferase enzymes: DNMT1, DNMT3a and DNMT3b (Bestor, 2000) . These enzymes exhibit highly conserved catalytic domains which transfer a methyl group from S-adenosyl-Lmethionine to the C5 position of cytosine in CpG dinucleotides (Hermann et al., 2004) . DNMT1 is traditionally classified as a 'maintenance' DNA methyltransferase due to its in vitro preference for hemimethylated DNA substrates, its interaction with PCNA, and its localization to the replication fork (Bestor, 2000; Hermann et al., 2004) . DNMT3A and DNMT3B, on the other hand, are labeled de novo DNA methyltransferases as their activities are mostly independent of sister strand methylation patterns (Bestor, 2000; Hermann et al., 2004) . It is clear, however, that these classifications are oversimplified as DNMT1 is known to possess de novo methylation activity and because DNMT1 can mediate de novo methylation spreading in cis (Bestor, 2000; Hermann et al., 2004) .
CpG dinucleotides have been progressively depleted from the genome throughout evolution and remaining CpG dinucleotides exhibit a high frequency of methylation (Gardiner-Garden and Frommer, 1987) . It is proposed that these methylated CpG dinucleotides maintain repetitive DNA such as Alu sequences and transposons in a transcriptionally silent state (Bestor and Tycko, 1996) . However, clusters of CpG dinucleotides, referred to as CpG islands, are frequently found unmethylated within the 5 0 regulatory regions of many genes. Hypermethylation of these CpG islands typically leads to transcriptional silencing through the recruitment of methyl-CpG binding proteins which form complexes with histone deacetylases, histone methyltransferases and other chromatin remodeling enzymes (El-Osta and Wolffe, 2000) . Therefore, aberrant DNA methylation during viral infection may be associated with transcriptional silencing not only of viral genomes, but also of critical cellular regulatory genes including those involved in the immune response or tumor suppression.
Recently, an Epstein-Barr virus oncogene product, latent membrane protein 1 (LMP1), was shown to repress the E-cadherin metastasis suppressor gene through induction of DNMT1 (Tsai et al., 2002) . While this report established a link between the LMP1 viral oncogene and DNMT1 regulation, the mechanism by which DNMT1 was induced was not clear. We have recently demonstrated that the DNMT1 gene is positively regulated by the E2F1 transcription factor and that cells with an inactivated pRb pathway exhibit elevated, cell cycle-independent expression of Dnmt1 (McCabe et al., 2005) . Considering that many viral oncogenes bind to and inactivate the pRb pocket protein family and that DNA methylation appears to play an important role during viral infection and transformation, we have investigated the mechanism by which DNMT1 is regulated by the human polyomavirus BKV. Latent BKV infection is nearly ubiquitous among humans with primary infection typically occurring in childhood with subclinical effects (Tognon et al., 2003) . However, BKV reactivation has been implicated in hemorrhagic cystitis observed in immunosuppressed bone marrow transplant patients (Azzi et al., 1994) . Furthermore, BKV infection has been associated with neuroblastoma, pancreatic islet tumors, and several urinary tract tumors suggesting that BKV may play a causative role in the etiology of many cancers (Tognon et al., 2003) . We demonstrate herein that BKV activates DNMT1 as a result of pocket protein inactivation and subsequent E2F activation.
Results
BKV large TAg activates mouse and human DNMT1 promoters Viral oncogenes stimulate remarkably elevated E2F activity as a result of pocket protein family inactivation (Hiebert et al., 1989; Chellappan et al., 1992; Harris et al., 1998) . For example, the dihydrofolate reductase (DHFR) promoter, a well-characterized E2F target, was strongly activated when cotransfected along with BKV TAg (Figure 1a ). We recently demonstrated that the murine and human DNMT1 genes are positively regulated by E2F1 and negatively regulated by pRb (McCabe et al., 2005) . In order to determine if the DNMT1 gene was stimulated by the BKV TAg oncogene, luciferase reporter assays were performed with constructs containing the upstream promoter sequences from the murine and human DNMT1 genes. The murine Dnmt1 promoter was potently activated by BKV TAg when cotransfected into mouse NIH3T3 cells (Figure 1b) . Similarly, when the human DNMT1 luciferase construct was cotransfected into human LNCaP cells along with BKV TAg, significant promoter activation was also observed (Figure 1c ). LNCaP cells were utilized because they retain intact pRb and p53 pathways and prostate epithelial cells have recently been shown to be a normal target of BKV infection in humans (Das et al., 2004) .
Pocket protein inactivation is critical for DNMT1 promoter activation
In order to investigate the role of pocket protein inactivation in the stimulation of DNMT1 by BKV, we utilized a BKV E109K TAg mutant which no longer interacts with pocket proteins due to disruption of its LXCXE motif at AA105-109 (Harris et al., 1998) . The requirement for pocket protein inactivation in the stimulation of E2F activity is demonstrated by the inability of BKV E109K TAg to fully activate the DHFR promoter ( Figure 1a) . Similarly, E109K TAg exhibited 81 and 79% reductions in murine and human DNMT1 promoter activation, respectively, compared to its wild-type counterpart (Figure 1b and c) .
In addition to inactivating pocket proteins, polyomavirus TAg also potently disrupts p53 function (McCormick et al., 1981) . As p53 has been reported to repress Dnmt1 expression (Peterson et al., 2003) , we assessed the ability of the adenoviral E1a oncogene to activate DNMT1 promoter activity as this protein inactivates the pocket proteins, but does not inactivate p53. We found that similar to DHFR (Figure 1d ), the mouse and human DNMT1 promoter reporter constructs were considerably activated by E1a (Figure 1e and f). In order to investigate the contribution of pocket protein inactivation to DNMT1 promoter stimulation in the context of E1a, we utilized the E1a CXdl mutant which contains a 29 amino-acid deletion within conserved regions 2 and 3 which abolishes its pocket protein binding activity (Moran, 1988) . Similar to BKV E109K TAg, E1a CXdl failed to fully activate the DHFR, mouse Dnmt1, and human DNMT1 promoters ( Figure  1d , e and f).
Finally, in order to directly assess the role of pRb, p107 and p130 in Dnmt1 promoter regulation, we performed Dnmt1 promoter reporter assays in wild-type murine embryonic fibroblasts (MEFs) compared to triple knockout (TKO) MEFs lacking pRb, p107 and p130 (Sage et al., 2000) . As hypothesized, genetic inactivation of the pocket protein family prompted a dramatic increase in Dnmt1 promoter activity compared to wild-type controls ( Figure 2a ). Furthermore, when the effect of BKV TAg on the Dnmt1 promoter was compared between these two genotypes, a significantly reduced activation was observed in Tko MEFs ( Figure 2b ) very similar to findings shown in Figure 1b with the pocket protein interaction deficient TAg mutant. Taken together, these findings suggest that the vast majority of DNMT1 induction by BKV TAg and adenovirus E1a is dependent upon the interaction between these viral oncogenes and the pocket proteins.
E2F binding is required for DNMT1 promoter activation by viral oncogenes
In order to demonstrate that elevated E2F activity is required for DNMT1 stimulation, we assessed the ability of viral oncogenes to activate DNMT1 promoters in which their E2F binding sites were either mutated or deleted. A mutant murine Dnmt1 promoter in which the two E2F binding sites were mutated via site-directed mutagenesis (Figure 3a ) has previously been shown to have significantly reduced activation in response to exogenous E2F1 (McCabe et al., 2005) . In comparison to the wild-type Dnmt1 promoter, cotransfection with BKV TAg or E1a activated the E2F-sites mutated Dnmt1 promoter 72 and 68% less effectively (Figure 3a) . Likewise, removal of the E2F site within the human DNMT1 promoter via a 61 base pair 3 0 deletion (Figure 3b ) was previously shown to completely relieve repression of DNMT1 by exogenous pRb (McCabe et al., 2005) . As previously reported, deletion of this region induces a 58% decrease in basal promoter activity likely due to loss of E2F binding; however, considerable promoter activity remains demonstrating that this deletion does not completely prevent promoter activity (McCabe et al., 2005) . Similar to its mouse homolog, the human DNMT1 promoter required its E2F binding site for substantial activation by BKV TAg and E1a (Figure 3b ). These data demonstrate that TAg and E1a-mediated DNMT1 activation is due in large part to aberrant E2F activity following pocket protein inactivation.
DNMT1 levels are elevated by BK virus infection
In order to examine regulation of DNMT1 during an active viral infection, we examined DNMT1 protein levels during infection of primary human kidney proximal tubule epithelial (HPTE) cells with BKV. HPTE cells were utilized, since the epithelium of the proximal tubule is a normal target of BKV infection in vivo. BKV TAg production was first detected 36 h postinfection and reached near maximal levels by 48 h postinfection (Figure 4a) . Correlating with the appearance of TAg, we observed hyperphosphorylation of the retinoblastoma protein (pRb) and elevated proliferating cell nuclear antigen (PCNA), a well-characterized E2F target gene (Figure 4a ). In an identical fashion, DNMT1 protein levels increased greater than four-fold by 48 h post-BKV infection (Figure 4a) . Interestingly, DNMT1 levels remained elevated 11 days postinfection, again in close correlation with the expression of TAg, pRb hyperphosphorylation, and elevated E2F activity (Figure 4b) .
In order to determine if DNMT1 upregulation was occurring at a transcriptional level, semiquantitative RT-PCR was performed. Similar to protein analyses, 2 days post-BKV infection marked upregulation of DNMT1, but not DNMT3B, was first observed compared to mock-infected samples (Figure 5a and b) . Additionally, DNMT1 activation correlated closely with the activation of multiple E2F targets including E2F1 itself, cyclin E2, cyclin B2 and DHFR (Figure 5a and b and data not shown). The finding that DNMT1 mRNA was upregulated 2.25-fold while the protein was upregulated a more considerable 4.0-fold may reflect the relatively short 4 h half-life of DNMT1 mRNA (Slack et al., 1999) compared to a longer (B6-9 h) protein half-life (Agoston et al., 2005) or may indicate the involvement of additional post-transcriptional mechanisms in DNMT1 protein activation. These data demonstrate that the endogenous DNMT1 gene is positively regulated during BK virus infection and that this stimulation correlates with E2F activation.
The role of E2F activity in BKV-mediated activation of DNMT1 was further investigated by performing luciferase reporter assays during an active viral infection. Wild-type and DE2F versions of the DNMT1 reporter construct were transfected into HPTE cells 48 h post-BKV infection and cells were harvested for analysis 3 days later when DNMT1 mRNA and protein levels were demonstrated to be elevated (Figures 4b and 5 ). As expected, activity of the wild-type DNMT1 promoter was elevated 7.0-fold 5 days post-BKV infection (Figure 6 ). On the other hand, the DNMT1 promoter lacking its E2F binding site failed to exhibit any significant activation following viral infection (Figure 6 ). These findings demonstrate that BKV infection of primary human cell cultures induced elevated E2F activity, which was strictly required for activation of DNMT1. 
Discussion
Aberrant overexpression of DNMT1 induces de novo methylation of susceptible CpG islands (Vertino et al., 1996; Biniszkiewicz et al., 2002; Feltus et al., 2003) . Furthermore, disruption of normal DNMT1 regulation appears crucial for the initiation and progression of transformation and tumorigenesis in multiple cell and tumor types (MacLeod and Szyf, 1995; Bakin and Curran, 1999; Slack et al., 1999; Etoh et al., 2004) . In this report, we demonstrate that the large TAg of the human polyomavirus BKV and adenovirus E1a are capable of potently activating transcription from the DNMT1 promoter. This activity strictly requires viral oncogene-mediated pocket protein inactivation and subsequent release of active E2F. These findings, combined with previous studies documenting the effects of DNMT1 overexpression, suggest that aberrant regulation of DNA methyltransferase activity by the pRb/E2F pathway may be important not only during viral lytic infection, but also in virally induced transformation and tumorigenesis.
Indeed, adenovirus infection has been shown to promote de novo DNA methylation of both viral and cellular genes in hamster cells (Heller et al., 1995; Remus et al., 1999) . Another group has also demonstrated that infection of primary T cells with HIV leads to hypermethylation and silencing of the interferon g gene (Mikovits et al., 1998) . Interestingly, this hypermethylation correlated with upregulation of DNMT1 mRNA and could be prevented by decreasing DNMT1 levels with an antisense DNMT1 (Mikovits et al., 1998) . Although the molecular mechanism of HIV-mediated DNMT1 transactivation was not identified, the study provides further evidence that viral infection activates DNMT1 and promotes hypermethylation of specific target genes. These findings raise important questions regarding the mechanism of DNA methylation targeting and the role that elevated DNA methyltransferase activity plays during viral infection. The finding that repetitive Alu elements, transposons, and integrated viral genomes are hypermethylated within cellular genomes (Sutter and Doerfler, 1980; Kochanek et al., 1993; Yoder et al., 1997) suggests that increased DNA methyltransferase activity may be a host defense mechanism against the expression or mobility of foreign DNA. However, the finding that HIV-infection and subsequent DNMT1 activation lead to methylation of interferon g, a gene critical to the host antiviral defense, suggests that DNMT1 stimulation might be an evolutionary adaptation enabling viruses to replicate their genomes before their host cell is targeted by an immune response. It will be interesting to utilize techniques such as differential methylation hybridization (DMH) or restriction landmark genomic scanning (RLGS) to identify on a global scale hyper-and hypomethylated CpG island loci, which are targeted by DNMT1 following viral infection.
While DNA methylation may function as a host defense mechanism, it may also play an as yet uncertain role in promoting viral replication. Considering the increased DNMT1 levels induced by viral infection and the frequent dense methylation of integrated viral genomes, it is somewhat surprising that most DNA viruses exhibit undetectable DNA methylation of their virion DNA (Kaye and Winocour, 1967) . However, infection and viral replication are still somehow abrogated by treatment with DNA methyltransferase inhibitors (5-azacytidine, 5-azadeoxycytidine, or 5,6-dihydro-5-azacytidine) in multiple cell types infected with HIV, SV40, or the iridovirus frog virus 3 (Goorha et al., 1984; Johnson-Thompson and Albury, 1988; Bouchard et al., 1990) . Inhibition of HIV replication with 5-aza treatment occurred within the first 6 h postinfection suggesting that some aspect of early retroviral replication requires DNA methyltransferase activity (Bouchard et al., 1990) . While the direct mechanism(s) by which these 5-aza compounds inhibited viral DNA replication is not clear, these findings lend support to the idea that DNMT1 activation may be an adaptation by viruses to increase the productivity of their infection.
Interestingly, the increased cellular capacity to methylate genes due to increased DNMT1 levels following viral infection appears to also promote the methylation of many tumor suppressor genes frequently silenced in human cancers. Infection of human mesothelial cells in vitro with SV40 led to a progressive methylation of DcR1, RRAD, RASSF1A, HIC1, CRBP1 and TMS1 with increasing passages (Suzuki et al., 2005) . Furthermore, when the presence of SV40 sequences and DNA hypermethylation were studied in primary malignant mesotheliomas, leukemias, and lymphomas a significant correlation was identified between SV40 positivity and aberrant hypermethylation of several genes (Toyooka et al., 2001b; Shivapurkar et al., 2004) . Among the genes whose hypermethylation correlated with SV40 positivity were RASSF1A, CDH1, CDH13, CDKN2A, DcR1/2, CRBP and DAPK (Toyooka et al., 2001b; Shivapurkar et al., 2004) . The hypermethylation of these critical regulatory genes in correlation with viral infection implies that virusmediated activation of DNMT1 may promote transformation and tumorigenesis through the targeted silencing of multiple tumor suppressor genes.
In addition to the aforementioned studies investigating SV40 infection in mesothelioma, leukemia and lymphoma, viruses have also been implicated in the etiology of several other cancers. BK virus, for example, has been detected in neuroblastoma, pancreatic islet tumors, and several urinary tract tumors including those of the bladder and prostate (reviewed in (Tognon et al., 2003) ). In one recent study, BKV TAg transcript and protein were detected in 15 of 16 (94%) and 15 of 21 (71%) prostate cancers, respectively (Das et al., 2004) . Immunohistochemistry found TAg protein in these samples to be localized within premalignant lesions suggesting that this viral oncogene may play an early role in prostate cancer initiation (Das et al., 2004) . Another cancer that is clearly associated with viral infection is cervical carcinoma. Nearly 100% of patients with cervical cancers have been infected by a high-risk human papillomavirus and their tumors retain expression of the HPV E6 and E7 oncogenes (reviewed in (Munger, 2002) ). In support of our findings, a recent gene expression profiling study of early stage cervical cancers infected with high-risk HPVs found that among the 240 upregulated genes, DNMT1 was activated 2.64-fold compared to normal cervical keratinocytes (Santin et al., 2005) . Interestingly, cyclin D2, cadherin 13, Pcadherin, and SOCS1 were significantly downregulated in the HPV positive cervical cancers (Santin et al., 2005) and have all been demonstrated to be hypermethylated in other cancers (Jarrard et al., 1997; Sinclair et al., 1995; Toyooka et al., 2001a; Yoshikawa et al., 2001) . Also in support of our hypothesis that E2F activity is responsible for DNMT1 activation, 43 of 240 (18%) genes upregulated in high-risk HPV positive cervical cancers (Santin et al., 2005) are previously identified E2F target genes (Ishida et al., 2001; Ma et al., 2002; Ren et al., 2002) suggesting that elevated E2F activity is a hallmark of virus-induced cancer.
Not surprisingly, a wide array of other cancer types also exhibit E2F pathway activation independent of viral infection. Recently, Rhodes et al. (2005) examined gene expression data from 65 independent microarray studies for transcriptional signatures of specific transcription factor pathway activation. They found E2F pathway activation to the most commonly altered pathway (observed in lymphoma, leukemia, glioblastoma, medulloblastoma, lung cancer, hepatocellular carcinoma, high-grade breast cancer, etc.) of the many transcription factor pathways analysed (Rhodes et al., 2005) . These findings suggest that activation of DNMT1 by the E2F pathway may be a widespread event in human cancer and that therapeutic targeting of DNA methyltransferase activity may be useful in cancer treatment.
Evidence supporting a role for viral infection in the etiology of human cancers appears to be increasing with advances in technology that allow more sensitive detection of viral genomes, transcripts and protein products. Considering that viruses are highly evolved to promote aberrant activation of DNA replication and S phase progression machinery, it should be little surprise that viruses might contribute to tumor initiation and progression. Indeed, viral genomes and viral oncogenes have been utilized for over 25 years to immortalize and transform cells in vitro. Only recently, Boehm et al. (2005) have finally established conditions which can transform human fibroblast cells without the assistance of viral oncogenes. As expected, inactivation of the pRb pathway through the use of a short hairpin RNA was critical for transformation in the absence of large TAg (Boehm et al., 2005) . As we have demonstrated here, inactivation of pRb and subsequent E2F activation likely not only promote resistance to growth arrest and increased proliferation, but also promote dysregulation of DNA methyltransferase activity which heritably silences tumor suppressor genes normally required for the maintenance of cellular homeostasis and the prevention of tumorigenesis.
Materials and methods
Cell culture and viral infection NIH3T3 murine fibroblast and LNCaP human prostate adenocarcinoma cells were obtained from American Type Culture Collection (Manassas, VA, USA). NIH3T3 cells were grown in DMEM media supplemented with 10% fetal bovine serum (FBS), L-glutamine, penicillin and streptomycin. LNCaP cell were grown in RPMI-1640 media supplemented with 5% FBS, L-glutamine, penicillin and streptomycin. Primary HPTE cells were obtained as previously described (Humes et al., 2002) . Wild-type and Rb
TKO MEF cultures were kindly provided by Tyler Jacks (Sage et al., 2000) . These cell cultures were maintained in DMEM media supplemented with 10% FBS, L-glutamine, penicillin and streptomycin. All analyses with these MEF cultures were performed during passages 4 and 5 prior to the onset of senescence. HPTE cells were maintained in UltraMDCK Media (BioWhittaker, Walkersville, MD, USA) supplemented with 1 ml/l of insulin, transferrin, ethanolamine, selenium (BioWhittaker), 60 mg/l of epidermal growth factor (R & D Systems, Minneapolis, MN, USA) and 0.010 ml/l of triiodothyronine (BioWhittaker). For viral infection, HPTE were grown in six-well dishes to 70% confluence, and infected with BKV at an MOI of 5 FFU/cell as previously described (Low et al., 2004) .
Luciferase reporter assays Cells were plated into six-well tissue culture plates at a density of approximately 1 Â 10 5 cells per well. After 24 h cells were transiently transfected in triplicate utilizing FuGENE6 (Invitrogen, Carlsbad, CA, USA) or Effectene (Qiagen, Hilden, Germany) according to the manufacturer's directions with the designated combination of expression plasmids at 1.0 mg, 1.0 mg luciferase reporter plasmid, and 0.5 mg pSV-b-galactosidase (Promega) for transfection normalization. DNMT1 promoter luciferase reporter plasmids are as previously described (McCabe et al., 2005) . The dihydrofolate reductase (DHFR) promoter luciferase plasmid was kindly provided by Erik Knudsen. Cells were harvested 48 h post-transfection, lysed and analysed for luciferase and b-galactosidase activity with luciferase substrate and Galacto-Light Plust b-Galactosidase chemiluminescent reporter assay (Tropix, Foster City, CA, USA). All samples were measured on a Monolight s 2010 luminometer (Analytical Luminescence Laboratory, San Diego, CA, USA). Relative luciferase activity was defined as the ratio of luciferase activity to b-galactosidase activity.
Western blot analysis Cells were harvested by mechanical disruption with cell scrapers followed by gentle centrifugation. Cell pellets were then lysed in appropriate volumes of lysis buffer (50 mM Tris (pH 8.0), 120 mM NaCl, 0.5% nonidet P-40, 1 mM EGTA, 100 mg/ml phenylmethanesulfonyl fluoride, 50 mg/ml aprotinin, 50 mg/ml leupeptin, and 1.0 mM sodium orthovanidate) for 1 h on ice. Cellular debris was then pelleted by centrifugation and supernatants were collected and quantitated using a Bradford protein assay (BioRad, Hercules, CA, USA). Equal amounts of protein were then separated on precast Tris-Glycine SDSpolyacrylamide gels (Novex, Carlsbad, CA, USA) and transferred to Hybond nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Membranes were then blocked, probed and developed as previously described (McCabe et al., 2005) . Primary antibodies were obtained as follows: DNMT1 (Santa Cruz, sc-10221, Santa Cruz, CA, USA), TAg (pAb416, Crawford and Harlow, 1982) ), pRb (Pharmingen, 554136, San Diego, CA, USA), PCNA (Santa Cruz, sc-9857) and actin (Santa Cruz, sc-1615) .
RNA isolation and semiquantitative RT-PCR analysis
Total cellular RNA was extracted from approximately 5 Â 10 6 cells with Qiagen's RNeazy Mini Kit according to the manufacturer's directions. Of the resulting total RNA 2 mg was reverse transcribed using the ThermoScript RT-PCR system (Invitrogen) as previously described (McCabe et al., 2005) . Variable numbers of PCR cycles were performed to ensure analysis of samples during the linear phase of amplification. The gene-specific primer sequences are as follows: DNMT1 forward 5 0 -cctgctctactggagcgacgag-3 0 , reverse 5 0 -gccgcacagcatctccacgtc-3 0 ; DNMT3B forward 5 0 -ggaagatggggatggctctg-3 0 , reverse 5 0 -gcctgcacgacgcaccttcg-3 0 ; E2F1 forward 5 0 -catccagctcattgccaagaag-3 0 , reverse 5 0 -gatcccacctacggtctcctca-3 0 ; Cyclin E2 forward 5 0 -ggaaccacagatgaggtccatac-3 0 , reverse 5 0 -gcacactggtgacaactgtcc-3 0 ; HPRT forward 5 0 -ctggcgtcgtgattagtgatg-3 0 , reverse 5 0 -ggattatactgcctgaccaag-3 0 .
